The FDA granted 510(k) clearance to Gleamer's BoneView AI software for pediatric fracture detection. This expands the tool's authorized use to include pediatric populations in clinical settings.
Our readExpanding FDA clearance to pediatric patients allows health systems and imaging centers to utilize BoneView across a broader demographic, improving diagnostic confidence and standardizing trauma care for children.